Putting the mouth where the money is Other October 30, 2023 A Medicare claims analysis identified four no- or low-value oncology interventions: (1) denosumab for castration sensitive prostate cancer, (2) a…
Expansive results Other July 6, 2023 This comprehensive review of the impact of Medicaid expansions ushered in by the Affordable Care Act indicates an associated increase…
